Quantitative Sensory Testing (QST) as a tool to assess and quantify thoracic pain in patients with chronic interstitial lung disease (ILD)

• Conditions: J84.9; R07.4; Interstitial pulmonary disease, unspecified; Chest pain, unspecified

• Registration Number: DRKS00022978
• Lead Sponsor: niversitätsmedizin Essen, Ruhrlandklinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-11-12
• Study Start: 2020-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 79

Inclusion Criteria

Outpatients and inpatients of the Ruhrlandklinik;

Interstitial lung disease diagnosed according to ATS/ERS criteria 2002 or 2013 (3): IPF, NSIP, COP, EAA, DIP, RBILD, PAP

Exclusion Criteria

Incompletely documented history or
unclassifiable ILD

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of the pain sensitivity of patients with interstitial lung diseases with and without thoracic pain measured on the day of patient inclusion using quantitative sensory testing.

Secondary Outcome Measures

Name	Time	Method
Comparison of clinical data between patients with and without thoracic pain.